广州没毛病医疗器械有限公司
服务热线: 0755-2955 6666
语言切换:

Single breakthrough is urgently needed to avoid being subject to domestic medical device technology

日期: 2019-05-23
浏览次数: 124

In the confrontation between system and counter-system, core technology and comprehensive strength are the way to be invincible.

The cruel Sino-US trade war, due to the lack of core technology such as chips, restricts many high-tech industries in China. From the revival of Huawei to Haikangwei, a series of 'disconnection' are constantly reminding domestic enterprises that core technology must not be subject to others.

The same is true of the medical industry. An expert reminds us that there have been cases of Russian medical equipment being subject to Western sanctions. Chinese medical equipment enterprises must not stay in integrated innovation, but surmount technical barriers and charge for core components and technologies. Hu Jun, founder and CEO of Hangzhou Zhaoguan Sensing Technology Co., Ltd., believes that it is more realistic for many innovative medical device manufacturers to make full use of their own technological advantages and achieve a single breakthrough in core technology.

According to the reporter's understanding, Zhaoguan Science and Technology is called 'Huawei Spirit' by some domestic medical experts. It has achieved a single breakthrough in the field of sleep breathing monitoring. The next step is to make market breakthroughs.

This is a long and arduous road, but also a necessary one.

'More than 80% of China's high-end medical equipment relies on imports, and most of the core technologies, materials or components are monopolized by foreign companies.' Wu Mingjiang, member of the CPPCC National Committee and former vice president of the Chinese Medical Association, said that even if high-end medical equipment is manufactured and assembled domestically, it is necessary to import core components or materials, lacking core technology and low profits.

This is an industry with high technology density and difficulty in R&D. It has a long R&D cycle and complex technology. It needs interdisciplinary research and huge investment. A medical device product from research and development, declaration, clinical trials, to the final market, at least three or five years. So the early domestic medical device enterprises mostly took a way of imitation and assembly. In this case, once the transfer of technology is limited, it will be passive.

'It's a long and arduous road, but it's also a necessary one.' Hu Jun judged. As early as 2015, Chen Siping, a well-known medical expert and counselor of the Guangdong Provincial People's Government, put forward that big health is the engine of future global economic development, and will also be an indispensable place for soldiers in national competition. Independent innovation will be the only way for Chinese medical enterprises to rise.

Seeking Single Breakthrough Based on Its Technical Advantage

Instead of imported products, the process of localization of medical equipment has already begun. On August 16, 2014, the State Health and Family Planning Commission and the Ministry of Industry and Information Technology jointly convened a conference on promoting the development and application of domestic medical equipment, which made it clear that the transformation and upgrading of domestic medical equipment industry should be promoted.

Since then, the state has promulgated 'Made in China 2025', 'Healthy China 2030' Program Outline, '13th Five-Year Plan for the Development of Strategic Emerging Industries' and 'Guiding Opinions of the General Office of the State Council on Promoting the Healthy Development of the Pharmaceutical Industry', etc. to accelerate the development of domestic medical equipment has become an important strategy of the country.

With the implementation of relevant national support policies, domestic enterprises begin to concentrate on technological innovation. On the one hand, they catch up with the international advanced level in basic technology in an all-round way and bid for world-class products; on the other hand, they seek a single breakthrough according to their own technological advantages.

Domestic manufacturers have made some breakthroughs in succession, and a number of core equipment and key components have been localized. Since 2016, domestic enterprises such as DongSoft Medical, Shanghai Lianfeng Medical and Mingfeng Medical have launched self-developed PET/CT products, breaking the monopoly of imported products. Zhaoguan Science and Technology independently developed the first non-contact sleep monitoring equipment in China, UWB radar sleep monitoring system. It has won more than 20 patents at home and abroad. At present, it has obtained CFDA certification and has been recognized by nearly 100 third-class hospitals.

Not only is it not restricted to others, but it also overtakes in bends.

In fact, based on advanced AI, bioradar sensing, medical health testing, big data and other core technologies, Zhaoguan Technology has created a set of intelligent medical products with complete intellectual property rights system. This young entrepreneurship team, from the first day of its birth, adheres to the purpose of independent research and development, and practices the fundamentals of technological entrepreneurship. Ultra-wideband radar sleep monitoring system alone, technology investment is more than 50 million yuan, from 2014 to now, five years sharpen a sword, and in 50 entrepreneurship team, 90% of the technical developers, including the national 'Thousand People Program' experts, well-known University doctoral tutors and other cutting-edge talents.

Megawatt UWB radar sleep monitoring system adopts a different way from the original standard, and avoids the drawbacks of traditional products. Previously, the golden standard in the field of sleep breathing was a polysomnography (PSG) system developed and completely dominated by foreign manufacturers. The system has inherent defects. Patients need to attach sensors such as electrodes to their bodies, which will have an impact on sleep, and then affect the monitoring effect.

Zhang Liqiang, director of the Sleep Respiration Center of the Third Hospital of Peking University and secretary-general of the Sleep Branch of the Chinese Medical Association, praised Zhaoguan Ultra-Wideband Radar Sleep Monitoring System, saying that he hoped that Zhaoguan Science and Technology would contribute to the best scheme in China to the world gold standard, just like Hua5G. It is reported that the product has been selected as the 'national key research and development plan for 13th Five-Year' based on the 'medical Internet +' domestic innovative medical device application demonstration.

Faced with blockade and strangulation, how will China's science and technology enterprises deal with it? Perhaps Huawei's sustained independent innovation promoted by Ren Zhengfei's 'extreme survival' theory has given the correct answer. In the view of Hu Jun, the founder and CEO of Zhaoguan Science and Technology, it is essential to know whether the core technology is mastered by me. Only by mastering the core technology can Chinese enterprises develop and grow.


  • Relevant news / News More
  • 点击次数: 124
    2019 - 05 - 23
    In the confrontation between system and counter-system, core technology and comprehensive strength are the way to be invincible.The cruel Sino-US trade war, due to the lack of core technology such as chips, restricts many high-tech industries in China. From the revival of Huawei to Haikangwei, a series of 'disconnection' are constantly reminding domestic enterprises that core technology must not be subject to others.The same is true of the medical industry. An expert reminds us that there have been cases of Russian medical equipment being subject to Western sanctions. Chinese medical equipment enterprises must not stay in integrated innovation, but surmount technical barriers and charge for core components and technologies. Hu Jun, founder and CEO of Hangzhou Zhaoguan Sensing Techn...
  • 点击次数: 50
    2019 - 05 - 22
    In the early part of this month, the 81st China International Medical Devices Expo was held in Shanghai, at which the major medical device manufacturers showed their products. So, how about the revenue of these medical device companies last year? This paper collates the annual reports of 52 Listed Medical Devices Companies in China in 2018, and finds out the operation status of these medical devices companies through data.With revenue of 13.753 billion yuan and net profit of 3.719 billion yuan, Myry leads the domestic medical device industry.In 2018, thanks to the strong growth of the three major service sectors, Merry Medical continued to lead the domestic medical device industry with a revenue of 13.753 billion yuan (23.09% year-on-year growth) and net profit of 3.719 billion yuan (43.65...
Copyright ©2019 - 2020 No-Problem Medical Equipment Co., Ltd
Rhino Cloud Provides Enterprise Cloud Services
地址:中国·深圳·宝安中心区·宝源路F518时尚创意园15栋3层
Tel: 86 020-8203 9399
传真:+86 0755-2788 8009
邮编:330520
犀牛云提供云计算服务